Free Trial

89BIO (ETNB) Competitors

89BIO logo
$14.87 0.00 (0.00%)
Closing price 09/22/2025 04:00 PM Eastern
Extended Trading
$14.87 0.00 (0.00%)
As of 09:28 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ETNB vs. MENS, ACLX, PCVX, KRYS, ARWR, ACAD, ADMA, AAPG, MTSR, and MIRM

Should you be buying 89BIO stock or one of its competitors? The main competitors of 89BIO include Jyong Biotech (MENS), Arcellx (ACLX), Vaxcyte (PCVX), Krystal Biotech (KRYS), Arrowhead Pharmaceuticals (ARWR), ACADIA Pharmaceuticals (ACAD), ADMA Biologics (ADMA), Ascentage Pharma Group International (AAPG), Metsera (MTSR), and Mirum Pharmaceuticals (MIRM). These companies are all part of the "pharmaceutical products" industry.

89BIO vs. Its Competitors

Jyong Biotech (NASDAQ:MENS) and 89BIO (NASDAQ:ETNB) are both mid-cap pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

89BIO has a consensus price target of $25.81, suggesting a potential upside of 73.59%. Given 89BIO's stronger consensus rating and higher probable upside, analysts plainly believe 89BIO is more favorable than Jyong Biotech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jyong Biotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
89BIO
0 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.56

In the previous week, 89BIO had 21 more articles in the media than Jyong Biotech. MarketBeat recorded 30 mentions for 89BIO and 9 mentions for Jyong Biotech. Jyong Biotech's average media sentiment score of 0.47 beat 89BIO's score of 0.34 indicating that Jyong Biotech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Jyong Biotech
3 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
89BIO
8 Very Positive mention(s)
5 Positive mention(s)
12 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jyong BiotechN/AN/AN/AN/AN/A
89BION/AN/A-$367.08M-$3.61-4.12

Jyong Biotech's return on equity of 0.00% beat 89BIO's return on equity.

Company Net Margins Return on Equity Return on Assets
Jyong BiotechN/A N/A N/A
89BIO N/A -94.48%-80.92%

Summary

89BIO beats Jyong Biotech on 5 of the 8 factors compared between the two stocks.

Get 89BIO News Delivered to You Automatically

Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ETNB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ETNB vs. The Competition

Metric89BIOMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.21B$3.16B$5.79B$10.46B
Dividend YieldN/A2.36%5.61%4.57%
P/E Ratio-4.1221.03348.7126.86
Price / SalesN/A447.99554.60125.65
Price / CashN/A44.8326.0131.15
Price / Book4.459.8315.876.50
Net Income-$367.08M-$52.82M$3.29B$271.25M
7 Day Performance86.57%3.07%200.39%3.27%
1 Month Performance57.69%5.37%184.31%8.15%
1 Year Performance93.87%16.89%330.08%26.52%

89BIO Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ETNB
89BIO
2.4771 of 5 stars
$14.87
flat
$25.81
+73.6%
+81.6%$2.21BN/A-4.1240High Trading Volume
MENS
Jyong Biotech
N/A$51.82
-15.7%
N/AN/A$4.68BN/A0.0031Gap Down
High Trading Volume
ACLX
Arcellx
2.3311 of 5 stars
$75.20
-1.3%
$114.31
+52.0%
-9.7%$4.23B$107.94M0.0080Positive News
PCVX
Vaxcyte
2.0928 of 5 stars
$31.00
-3.6%
$106.25
+242.7%
-70.9%$4.18BN/A-7.54160Positive News
KRYS
Krystal Biotech
4.9328 of 5 stars
$155.71
+8.4%
$209.00
+34.2%
-10.2%$4.16B$290.52M31.65210Positive News
High Trading Volume
ARWR
Arrowhead Pharmaceuticals
4.22 of 5 stars
$28.67
-3.5%
$43.14
+50.5%
+54.1%$4.11B$3.55M-22.40400
ACAD
ACADIA Pharmaceuticals
4.2569 of 5 stars
$24.67
+4.5%
$29.65
+20.2%
+48.4%$3.98B$957.80M18.55510
ADMA
ADMA Biologics
3.3378 of 5 stars
$15.30
-5.0%
$27.67
+80.8%
-19.8%$3.84B$426.45M17.79530Positive News
AAPG
Ascentage Pharma Group International
N/A$38.63
-4.5%
N/AN/A$3.77B$134.35M0.00600
MTSR
Metsera
N/A$34.21
-4.1%
$63.50
+85.6%
N/A$3.75BN/A0.0081Trending News
Analyst Downgrade
Gap Up
MIRM
Mirum Pharmaceuticals
3.3931 of 5 stars
$74.19
-0.2%
$74.44
+0.3%
+89.8%$3.73B$336.89M-61.31140

Related Companies and Tools


This page (NASDAQ:ETNB) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners